Home›Stock Screener›Titan Biotech

Titan Biotech Share Price Today | Stock Price & Titan Biotech Share Screener

TITANBIO Specialty Chemicals
Live Share Price BSE
₹383.20
▼ -8.30 (-2.12%)
2026-10-05 00:00:00

As of October 5, 2026, the live Titan Biotech share price (BSE: TITANBIO) is ₹383.20, down 2.12% from the previous close, with shares trading between ₹380.25 and ₹397.95 in today's trading session, and a 52-week range of ₹220.20–₹1,424.50. Check TITANBIO 52-week chart for the annual price range and momentum. Use the Titan Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Titan Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹61 and net income of ₹11, with EBITDA of ₹14, an operating margin of 21.0% and a profit margin of 18.0%.

Titan Biotech Market Cap ₹1,617.60 Cr.
TITANBIO P/E Ratio (TTM) 48.02
Titan Biotech P/B Ratio 8.96
EPS (TTM) ₹7.23
Dividend Yield 0.13%
Debt to Equity 0.03
TITANBIO 52 Week High ₹1424.50
Titan Biotech 52 Week Low ₹220.20
Operating Margin 21.00%
Profit Margin 18.03%
TITANBIO Revenue (TTM) ₹61.00
EBITDA ₹14.00
Net Income ₹11.00
Total Assets ₹214.00
Total Equity ₹182.00

Titan Biotech Share Price Chart

Track the current stock price of Titan Biotech with an interactive chart. Analyse TITANBIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Titan Biotech stock quote in one place.

The quote of ₹383.20 sits between the 52-week low of ₹220.20 and the 52-week high of ₹1,424.50, and the latest session moved -2.12% from the previous close.

Titan Biotech Company Profile - Fundamental Screener

Screen Titan Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TITANBIO shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE150C01029.

Company Details

Classification

Sector Chemicals
Industry Specialty Chemicals
Sub-Sector Specialty Chemicals
Segment E

Identifiers and Leadership

ISIN INE150C01029

Titan Biotech Balance Sheet Screener

Screen TITANBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹214, up from ₹175 in 2025.

Latest statistics put total assets at ₹214 and shareholder funds at ₹182, with a leverage ratio of 0.03.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 214 175 157 135 108 101 76 65 57 52
Current Assets 85 80 73 68 64 59 44 35 29 30
Fixed Assets 62 57 52 36 35 34 31 29 14 13

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 6 4 4 4 5 9 14 15 20 16
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 182 153 134 110 86 73 42 34 26 24
Share Capital 8 8 8 8 8 8 8 8 8 8
Reserves & Surplus 173 145 125 102 78 61 31 24 17 15

Titan Biotech Income Statement Screener - Profit & Revenue Analysis

Screen Titan Biotech income statement and profit fundamentals. Analyze TITANBIO quarterly results. Titan Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹61 and net profit was ₹11, equal to earnings per unit of ₹2.63, at an operating margin of 21%.

In that period expenses were ₹47, interest cost ₹0 and tax ₹2. The next period listed, 2026-Mar, shows revenue of ₹51 and net profit of ₹7.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec

Revenue and Expenses

Revenue 61 51 58 56 47 37 40 40 44 40 46 44 35 37 31
Expenses 47 39 46 45 38 31 33 32 35 33 35 35 27 30 26

Operating Costs and Margins

EBITDA 14 12 12 11 10 6 6 8 9 8 11 9 8 7 4
Operating Profit % 21.00% 20.00% 19.00% 17.00% 19.00% 13.00% 13.00% 19.00% 19.00% 18.00% 23.00% 20.00% 23.00% 19.00% 14.00%
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 13 10 11 9 8 5 5 7 8 6 10 8 7 6 4
Tax 2 4 2 2 1 1 1 0 1 1 3 2 1 1 0
Net Profit 11 7 9 8 7 4 4 7 6 5 7 7 6 5 3
EPS 2.63 1.63 10.32 9.40 8.30 4.90 5.31 8.10 7.74 6.05 8.68 7.89 7.47 6.07 3.95

Titan Biotech Cash Flow Screener - Liquidity Fundamentals

Screen TITANBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹30, and net cash flow was an outflow of ₹4.

Over the same period, investing activities used ₹33 and financing activities used ₹2.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 30 20 21 21 22 19 6 6 2 0
Investing Activities -33 -10 -20 -21 -16 -5 -2 -4 -6 -8

Financing and Net Cash

Financing Activities -2 -8 -3 -2 -4 -11 -4 0 0 9
Net Cash Flow -4 2 -2 -2 2 4 0 1 -3 1

Titan Biotech Shareholding Pattern Screener

See Titan Biotech shareholding pattern with promoter, FII, and DII holdings. Check Titan Biotech promoter holding and ownership changes for TITANBIO on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 55.78%, foreign institutions 0.00%, domestic institutions 0.03% and the public 27.72%, spread across 17,457 shareholders.

The shareholder count was 17,457 in 2026-Mar, compared with 18,671 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 55.78% 55.78% 55.88% 55.88% 55.78% 55.78% 55.88% 55.88%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.03% 0.01% 0.01% 0.03% 0.03% 0.03% 0.23% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 27.72% 28.02% 29.20% 29.44% 29.65% 29.74% 30.06% 30.11%
Other Holding 16.47% 16.19% 14.91% 14.65% 14.54% 14.45% 13.84% 14.01%
Shareholder Count 17,457 18,671 16,370 16,328 16,040 16,367 15,876 15,850

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Titan Biotech. Titan Biotech dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.13%, compared with ₹2.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹2.00 and ₹2.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.50 0.13%
2025-March ₹2.00 0.44%
2024-March ₹2.00 2.37%
2023-March ₹1.80 1.70%
2022-March ₹1.50 3.81%
2021-March ₹1.50 2.86%
2020-March ₹1.00 2.69%
2019-March ₹0.00 0.00%
2018-March ₹0.75 8.33%
2017-March ₹0.75 5.96%

Titan Biotech Stock Index Membership - Nifty & Sensex

See which indices include Titan Biotech stock. Check TITANBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Titan Biotech is not part of any tracked indices.
Only major market indices are tracked in our system.

Titan Biotech Market Events Screener - Corporate Actions

Get Titan Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Titan Biotech stock events that may affect TITANBIO share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Dividend dated September 22, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-29 2026-09-29 Annual General Meeting NA -6.86%
2026-09-22 2026-09-22 Dividend ₹ 0.50 /share -7.59%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -3.73%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 5.29%
2026-02-20 2026-02-20 Split 2:10 32.89%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 10.81%
2025-11-11 2025-11-11 Quarterly Result Announcement NA -7.75%
2025-09-26 2025-09-26 Annual General Meeting NA 112.48%
2025-09-19 2025-09-19 Dividend ₹ 2.00 /share 102.73%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 2.29%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 0.55%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -7.10%
2024-11-12 2024-11-12 Quarterly Result Announcement NA -4.87%
2024-09-30 2024-09-30 Annual General Meeting NA 14.27%
2024-09-23 2024-09-24 Dividend ₹ 2.00 /share 14.63%

Titan Biotech Competitors Screener - Peer Stocks Comparison

Screen TITANBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Pidilite Industries 149,018 56.00 14,867 11.05% 2,471 29.48
SRF 73,697 33.92 15,894 7.20% 1,835 43.41
Gujarat Fluorochemicals 47,691 80.72 5,126 5.63% 574 36.03
Navin Fluorine International 41,734 53.60 3,379 41.21% 664 42.00
Himadri Speciality Chemical 33,562 42.51 4,832 3.60% 755 45.08
Aether Industries 22,166 95.87 1,181 34.17% 220 52.27
Deepak Nitrite 20,361 26.65 7,947 -5.01% 551 28.76
Atul 17,256 21.52 6,476 13.77% 689 28.93
Aarti Industries 16,864 32.51 8,291 13.78% 419 36.54
Fine Organic Industries 15,732 35.85 2,483 4.89% 417 49.47

Titan Biotech Company Announcements - News & Reports Screener

Screen TITANBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated October 2, 2026 and October 1, 2026.

Date Update Actions
2026-10-02 Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association -
2026-10-02 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-10-01 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-26 Closure of Trading Window -
2026-09-10 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-05 Intimation Regarding Weblink To Access The Annual Report For FY 2025-26 And Notice Of The 34Th Annual General Meeting For Shareholders Whose Email Ids Are Not Registered -
2026-09-05 Notice Of Thirty- Fourth (34Th) Annual General Meeting -
2026-09-05 Reg. 34 (1) Annual Report. -
2026-09-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-03 Intimation Of Record Date For The Purpose Of Final Dividend -
2026-09-03 Fixation Of Annual General Meeting Date Record Date Book Closure Date And E-Voting Date -
2026-09-03 Corporate Action-Fixes Book Closure For 34Th Annual General Meeting Of The Company -
2026-09-03 Corporate Action-Board recommends Bonus Issue -
2026-09-03 Board Meeting Outcome for Outcome Of Board Meeting Dated September 3 2026 -
2026-08-31 Board Meeting Intimation for Considering Bonus Issue Draft AGM Notice Draft Directors Report Fix AGM Decide Cut Off Date E-Voting Dates Record Dates Books Closure And Any Other Items With The Permission Of Chair. -
2026-08-31 Closure of Trading Window -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Board Meeting Outcome for Outcome Of Board Meeting Held On August 13 2026 -
2026-08-13 Unaudited Financial Results For Quarter Ended June 2026 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹383.20, within a 52-week range of ₹220.20 to ₹1,424.50. The P/E ratio is 48.02 and the P/B ratio is 8.96, with earnings per unit of ₹7.23. Market capitalisation stands at ₹1,617.60 Cr and the dividend yield is 0.13%. The company operates in the Chemicals sector, in the Specialty Chemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.